April 23, 2026 Trump Announces Drug Pricing Deal With Regeneron, Including Medicaid Price Cuts, $225 Praluent and $27B U.S. Investment
April 21, 2026 Title: Trump Administration Urges States to Verify Medical Providers in High-Risk Areas to Combat Healthcare Fraud
